WASHINGTON, DC - Energy and Commerce Committee Chairman Fred Upton (R-MI) and Oversight and Investigations Subcommittee Chairman Cliff Stearns (R-FL) responded to the recent letter from White House Counsel Kathryn Ruemmler that the White House would not provide internal White House communications related to Solyndra.
Committee Members Introduce FDA Reform Package to Protect American Patients, Jobs, and Medical InnovationOctober 14, 2011 | Press Release
WASHINGTON, DC - The United States for decades has led the global medical device industry, providing life-saving and life-improving devices to patients and employing more than two million people in device-related jobs. However, the Food and Drug Administration's unpredictable, inconsistent, and non-transparent handling of the review process has threatened our nation's medical device leadership, hurting patients, American jobs, and innovation.
WASHINGTON, DC - The Energy and Commerce Oversight and Investigations Subcommittee today heard startling testimony and released illuminating new documents regarding the unfolding Solyndra investigation.
WASHINGTON, DC - The U.S. House of Representatives today approved a common-sense new approach to regulation today that will improve environmental protections while protecting jobs and access to affordable electricity. H.R. 2273, the Coal Residuals Reuse and Management Act, provides for the safe management and disposal of coal ash in a way that preserves jobs and encourages recycling. The legislation passed the House with strong bipartisan support by a vote of 267 to 144.
WASHINGTON, DC -As part of an ongoing effort to improve the medical device review process, members of Congress recently invited innovators in the field to engage in a roundtable discussion about how the FDA's review process impacts their ability to make these devices accessible to American patients. The Subcommittees on Health and Oversight and Investigations have held several hearings to lay the foundation to strengthen the review and approval process. Legislative solutions to protect patients, jobs, and innovation will be introduced soon.
WASHINGTON, DC - The Subcommittee on Oversight and Investigations will hold a hearing on "Continuing Developments Regarding the Solyndra Loan Guarantee" this Friday, October 14, 2011, at 9:30 a.m. in room 2123 of the Rayburn House Office Building. The committee recently learned that the Treasury Department was concerned that the Department of Energy's restructuring of the Solyndra Loan in early 2011 was in violation of the law.